Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study asks: What's it like to give birth with remifentanil?

NCT ID NCT07030777

Knowledge-focused Sponsor: Nordsjaellands Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study interviewed 40 people—mothers who used remifentanil for labor pain and the midwives who cared for them—to understand their experiences. The goal was to learn about pain relief, side effects, safety, and communication during birth. The results will help guide future use of this pain medicine in Denmark.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

40 people

The number who actually took part.

Started

Mar 2025

Finished

Jun 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Study Population and Recruitment Setting Participants will be initially approached during their hospital admission after giving birth using remifentanil for labor analgesia at the labor ward in Hillerød. At this point, they will receive verbal and written information about the study and may be included if they provide informed consent. Midwives will be contacted after the relevant birth has taken place. They will be informed about the study and included if they agree to participate. If the mother and/or midwife consents to participate, they will be contacted by phone to schedule a semi-structured interview 4-10 days postpartum

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Women in labor aged 18 years or older who receive remifentanil for pain relief during childbirth at the labor ward in Hillerød. 2. Midwives who participate in childbirths where remifentanil is used as pain relief. Exclusion Criteria 1)Women in labor who do not speak Danish or English.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BIRTH are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BIRTH Labour analgesia Midwife Pain management in pregnant women Qualitative research Remifentanil

Contacts and locations

Locations

  • Department of Anaesthesia and Intensive care, University Hospital of Southern Denmark, Kolding, Denmark

    Kolding, Denmark

  • Præhospital center

    Næstved, Denmark

  • University Hospital of Copenhagen, North Zealand Hospital

    Hillerød, Select State, 3400, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.